Evolus (EOLS) Registration filing summary

Company overview and business model

• Operates as a global performance beauty company focused on the cash-pay aesthetic market, selling directly to licensed aesthetic practitioners.

• Pursues a non-reimbursed, aesthetic-only product strategy to avoid regulatory burdens and enhance customer value.

• Drives customer adoption through loyalty programs, co-branded marketing, promotional bundles, events, and pricing strategies.

Financial performance and metrics

• Incorporates by reference audited consolidated financial statements for the year ended December 31, 2025, and quarterly results for March 31, 2026.

• Ernst & Young LLP audited the financials and internal controls, with their reports included in the filing.

Use of proceeds and capital allocation

• Net proceeds from any securities sale will be used as specified in the applicable prospectus supplement.